Cancer Chemotherapy Update

New on the MedlinePlus Cancer Chemotherapy page: FDA Approves New Breast Cancer Drug 02/04/2015 02:00 PM EST Ibrance is targeted for postmenopausal women with advanced disease Source: HealthDay This email was sent to rssproject471@gmail.com.  Please click here to unsubscribe from the from the Cancer Chemotherapy MedlinePlus email list.  Follow MedlinePlus on Twitter   Search Cloud: See what people are searching for on MedlinePlus To change your subscription preferences or stop subscriptions anytime, log in to your User Profile with your e-mail address. For questions or problems with this service, please contact subscriberhelp.govdelivery.com. This is a free service provided by MedlinePlus and the U.S. National Library of Medicine, U.S. Department of Health and Human Services, National Institutes of Health. U.S. National Library of Medicine · 8600 Rockville Pike · Bethesda, MD 20894 · 888-346-3656